Additionally, for its anti-inflammatory and neuroprotective properties [111], PPAR-α activation by fenofibrate prevented prenatal maternal immune activation, which in a rat model is associated with the risk of developing schizophrenia in the offspring [112]. Here, PPARA is linked to schizophrenia.